New Insights into the Roles of p53 in Central Nervous System Diseases
International Journal of Neuropsychopharmacology · 31.07.2023 · 26 (7) · 465-473
DOI: 10.1093/ijnp/pyad030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Neuropsychopharmacology, online erschienen am 20.06.2023. Verfasst von Haili Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, the First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, Ch…. Hauptthemen laut MEDLINE: Neoplasms, Central Nervous System Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China, Development Plan of Medicine and Health Science and Technology of Shandong Province.
Abstract (Originalsprache)
The transcription factor p53, a widely accepted tumor suppressor, regulates the expression of many oncogenes and their downstream signaling pathways, resulting in a series of biological outcomes. Mutations and deletions of the p53 gene often occur in tumor tissues and are involved in their development. In addition to its role in tumors, p53 has a widespread expression in the brain and participates in most cell processes, such as dendrite formation, oxidative stress, apoptosis, autophagy, DNA repair, and cell cycle arrest. Therefore, abnormalities in p53 and its related signaling pathways play an important role in the diagnosis and treatment of central nervous system diseases. This review mainly discusses the latest findings regarding the role of p53 in some central nervous system diseases, such as brain tumors, Alzheimer disease, Parkinson disease, autism, epilepsy, spinocerebellar ataxia, and so on, to provide a comprehensive interpretation of the treatment of neurological diseases from a new perspective.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, the First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.
- School of Clinical and Basic Medical Sciences, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
- Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Development Plan of Medicine and Health Science and Technology of Shandong Province
- Academic Promotion Programme of Shandong First Medical University
Zitieren
APA
Li, H., Zhang, Z., Li, H., Pan, X., & Wang, Y. (2023). New Insights into the Roles of p53 in Central Nervous System Diseases. International Journal of Neuropsychopharmacology, 26(7), 465-473. https://doi.org/10.1093/ijnp/pyad030
Vancouver
Li H, Zhang Z, Li H, Pan X, Wang Y. New Insights into the Roles of p53 in Central Nervous System Diseases. International Journal of Neuropsychopharmacology. 2023;26(7):465-473. doi:10.1093/ijnp/pyad030
BibTeX
@article{Li2023,
author = {Li, Haili and Zhang, Ze and Li, Huixin and Pan, Xinyu and Wang, Yue},
title = {New Insights into the Roles of p53 in Central Nervous System Diseases},
journal = {International Journal of Neuropsychopharmacology},
year = {2023},
volume = {26},
number = {7},
pages = {465--473},
doi = {10.1093/ijnp/pyad030}
}
EUVIMED